Mother Calls for Ketamine Reclassification After Daughter’s Death at Age 22
1-Minute Brief
The case has renewed debate over ketamine's legal status and health risks associated with its recreational use.
Key Facts
- Isabelle Sapherson-Moralee died at age 22 after years of ketamine addiction, according to an inquest.
- Her mother has called for ketamine to be reclassified as a class A drug following her daughter's death.
- Ellie Wight, another user, experienced permanent bladder damage after ketamine use.
- Isabelle reportedly told her mother 'I can’t do it anymore' before her death.
- Ketamine use has been linked to severe bladder damage, sometimes referred to as 'ketamine bladder'.
What Happened
Isabelle Sapherson-Moralee died at age 22 after a period of ketamine addiction, prompting her mother to advocate for stricter drug classification. Other individuals have reported serious health consequences from ketamine use.
Why It Matters
The incident has brought attention to the potential dangers of recreational ketamine use and sparked calls for policy changes regarding its legal classification.
What's Next
Advocacy for reclassifying ketamine may influence future drug policy discussions. Further public health responses or official reviews may follow.
Sources
Confirmed by 2 independent sources
- BBC NewsCenter6h agoWoman warns of 'ketamine bladder' after drug use scarred hers for life
- The IndependentLeft2h agoYoung ketamine addict told mum ‘I can’t do it anymore’ before dying in agony, inquest hears
- The IndependentLeft39m agoGrieving mother wants ketamine reclassified as class A drug after daughter’s death
